Fresh hope of abolishing ‘eye-bleeding’ Ebola which kills up to 90% of victims, as pill shows ‘100% protection’
SCIENTISTS have found a pill that offers ‘100 per cent protection’ against Ebola – sparking hopes of eradicating the deadly ...
IFLScience1h
Pill That Cures Ebola In Monkeys Ignites Hopes For A Human Treatment
As well as protecting the monkeys from death, the treatment also evoked an immune response. Senior author Dr Thomas Geisbert ...
AZoLifeSciences on MSN3d
Bispecific antibodies for SARS-CoV-2 variant neutralization
Bispecific antibodies targeting multiple SARS-CoV-2 sites offer enhanced neutralization against emerging variants, advancing ...
Hoodline6d
Vanderbilt's High-Tech Quest for the Holy Grail of Antibody Therapy, $30M ARPA-H Grant Catapults AI Revolution in Disease Treatment
VUMC received up to $30M to develop AI for antibody therapy discovery, aiming to create an antibody-antigen atlas and ...
Medscape5d
New Bifunctional Drug Shows Sustained Effect in Alopecia Areata
In an alopecia areata trial, a novel bifunctional therapy that blocks signaling of the interleukin-7 and TSLP pathways ...
Business Wire5d
Celltrion's Infliximab, the First Monoclonal Antibody Biosimilar, Is Now Remdantry™ in Canada
Celltrion, Inc., a leading global biopharmaceutical company, announced today that its infliximab biosimilar will be marketed in Canada under the new b ...
Tech Explorist5d
Breakthrough antibody therapies offer hope for HIV treatment
Researchers from Imperial College London, working with the University of Oxford and Rockefeller University, have shown ...
The Manila Times9h
Akeso's Penpulimab Receives NMPA Approval for First-Line Treatment of Nasopharyngeal Cancer
Akeso Inc. (9926.HK) announced that its innovative, self-developed anti-PD-1 monoclonal antibody, penpulimab, has been officially approved by the National Medical Products Administration (NMPA) for ...
Science Daily9d
Research identifies key antibodies for development of broadly protective norovirus vaccine
Scientists have discovered a strategy to fight back against norovirus, a leading cause of gastroenteritis worldwide. Their new study identifies powerful antibodies capable of neutralizing a wide range ...